HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved synthesis and molecular modeling of 4beta,19-dihydroxyandrost-5-en-17-one, an excellent inhibitor of aromatase.

Abstract
4Beta,19-dihydroxyandrost-5-en-17-one (6) is an excellent competitive inhibitor of estrogen synthetase (aromatase). Alternate, improved synthesis of this inhibitor was established. Treatment of 19-(tert-butyldimethylsilyloxy)androst-4-en-17-one (8) with m-chloroperbenzoic acid gave a 1.4:1 mixture of 4alpha,5alpha-epoxide 9 and its 4beta,5beta-isomer 10. The mixture was reacted with diI. HClO4 in dioxane to produce principally 4beta,5alpha-diol 11 (80%) of which acetylation followed by dehydration with SOCl2 yielded 4beta,19-diacetoxy-5-ene compound 14 in good yield. Alkaline hydrolysis of diacetate 14 gave 4beta,19-diol 6. The minimum energy conformation of the powerfull aromatase inhibitor 6 was obtained with the PM3 method and compared with that of the structurally related diol steroid, 4-ene-5beta,19-diol 3, a weak competitive inhibitor.
AuthorsMitsuteru Numazawa, Keiko Yamada, Yoko Watari, Momoko Ando
JournalChemical & pharmaceutical bulletin (Chem Pharm Bull (Tokyo)) Vol. 50 Issue 5 Pg. 703-5 (May 2002) ISSN: 0009-2363 [Print] Japan
PMID12036037 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 4,19-dihydroxyandrost-5-en-17-one
  • Androstenes
  • Aromatase Inhibitors
  • Enzyme Inhibitors
  • Indicators and Reagents
Topics
  • Androstenes (chemical synthesis, pharmacology)
  • Aromatase Inhibitors
  • Enzyme Inhibitors (chemical synthesis, pharmacology)
  • Hydrolysis
  • Indicators and Reagents
  • Models, Molecular
  • Spectrophotometry, Infrared
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: